This Solicitation opportunity from Department Of Defense was posted on May 5, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
HYDROMORPHONE HYDRO
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract covers the procurement of Hydromorphone Hydrochloride Injection for veterinary use, specifically a 2 mg/mL concentration contained in 20 mg vials, classified under DEA Schedule C-II. The product is a clear, colorless liquid in 40 mg/20 mL strength and must be stored at controlled room temperature within a vault, protected from light, and not used if discolored or containing precipitate. Packaging and marking requirements conform strictly to the latest medical marking standards and DLA packaging protocols, ensuring secure and compliant handling. The contract includes technical and quality requirements referenced from the DLA Master List, with strict adherence to shelf-life specifications of 24 months without extension. The product is manufactured by Hikma Pharmaceuticals USA Inc. and distributed through Covetrus North America, LLC. The contract stipulates delivery terms with a single unit to be delivered within 88 days to a specified military medical material center in Kaiserslautern, Germany, with inspection and acceptance at the destination. Packaging must protect the injection from damage during transit and comply with commercial and military packaging standards. The ordering and procurement process is managed by the Department of Defense’s Medical Supply Chain under a firm contract with defined pricing and zero tolerance for quantity variance. Buyers are advised to verify regulatory compliance with FDA and defense information security requirements, and to route inquiries through designated contracting officials and product specialists as outlined.
General Info
Agency
NAICS
Place of Performance
ATTN CL VIII MED REQ PROCES ACT, APO, AE, 09227-0000, USSet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Submission Closed
Organization & Contact Information
Full Description
HYDROMORPHONE HYDROCHLORIDE INJECTION, VETERINARY
.
2MG/ML CONCENTRATION, 20MG VIAL DEA SCHEDULE C-II.
40MG/20ML STRENGTH, CLEAR, COLORLESS LIQUID.
.
UNIT OF ISSUE: EACH (EA)
.
STORE AT CONTROLLED ROOM TEMP -IN VAULT (C-II). PROTECT FROM LIGHT. DO
NOT USE THE INJECTION IF IT IS MORE THAN SLIGHTLY DISCOLORED OR CONTAINS
A PRECIPITATE.
.
SHALL BE MARKED IAW THE LATEST EDITION OF MEDICAL MARKING STANDARD NO. 1
HTTPS://WWW.DLA.MIL/LOGISTICS-OPERATIONS/PACKAGING/
.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
.
..
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
HIKMA PHARMACEUTICALS USA INC. 32655 P/N NDC00641-6254-01 COVETRUS NORTH AMERICA, LLC 4PG41 P/N 085079
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-3259
SECTION B
PR: 7016659052 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016659052 0001 EA 1.000
NSN/MATERIAL:6509016742670
DELIVERY (IN DAYS):0088
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:A
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
WK4FV1
W0CC USA MED MAT CTR EUR
CMR 469
ATTN CL VIII MED REQ PROCES ACT
APO AE 09227-0000
US
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
SPE2DP-26-T-3259
SECTION B
PR: 7016659052 PRLI: 0001 CONT’D
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
WK4FV1
W0CC USA MED MAT CTR EUR
USAMMC E DISTR AND TRANS DIVISION
LUDWIGSHAFENERSTRASSE 31 BLDG 2369
KAISERSLAUTERN 67657
DE
Need Ship Date:00/00/0000 Original Required Delivery Date:05/05/2026
SPE2DP-26-T-3259 NSN/Part Number: 6509-01-674-2670 Quantity: 1 EA Purchase Request: 7016659052QTY: 1 Delivery: 88 days ADO